IP Library Granted Patent US 7,686,771
Granted Patent B2
US 7,686,771 · App. 11/299,394 · Granted Mar 30, 2010

Method and apparatus for obtaining aliquot from liquid-based cytological sample

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,686,771
App. No.
11/299,394
Granted
Mar 30, 2010
Kind
B2
Abstract

Sample vials and methods of processing the sample vials are provided. The sample vial comprises a vial container, a sample collection chamber within the vial container, a vial cap configured to be mated with the vial container to enclose the collection chamber, an aliquot chamber, which may be carried by the vial cap or the vial container, and a valve mechanism for selectively sealing and unsealing the aliquot chamber from the collection chamber. The method may comprise flowing an aliquot of the sample from the collection chamber while the sample within the collection chamber is isolated from an environment exterior to the vial, sealing the aliquot chamber from the collection chamber to isolate the aliquot sample from the remaining sample portion, and transferring at least some of the remaining sample portion from the collection chamber to a microscope slide while the aliquot chamber is sealed from the collection chamber. The method further comprises reserving the slide for cytological screening of the sample, and reserving the aliquot sample for deoxynucleic acid (DNA) testing.

Claims (26)

1. A method of processing a vial having a collection chamber containing a fluid-based cervical-vaginal sample, a valve mechanism, and an aliquot chamber, wherein the valve mechanism comprises or is coupled to a wall of the aliquot chamber, and wherein the valve mechanism is biased to seal the aliquot chamber from the collection chamber unless actively actuated, the method comprising:

actuating the valve mechanism to unseal the aliquot chamber from the collection chamber;

flowing an aliquot of the sample from the collection chamber into the aliquot chamber while the collection chamber is isolated from an environment exterior to the vial;

terminating active actuation of the valve mechanism, wherein the biased valve mechanism automatically seals the aliquot chamber from the collection chamber to isolate the aliquot sample from a remaining portion of the sample in the collection chamber;

transferring at least some of the remaining sample portion from the collection chamber to a microscope slide while the aliquot chamber is sealed from the collection chamber;

reserving the slide for cytological screening of the sample for precursors to cervical cancer; and

reserving the aliquot sample for deoxynucleic acid (DNA) testing to determine the presence of high-risk Human Papilloma Virus (HPV) in the sample.

2. The method of claim 1 , further comprising examining the slide to cytologically screen the sample for the cervical cancer precursors.

3. The method of claim 1 , further comprising DNA testing the aliquot sample to determine the presence of high-risk HPV in the sample.

4. The method of claim 3 , wherein the DNA testing is performed in response to an abnormal result of the cytological screening.

5. The method of claim 4 , wherein the DNA testing is performed only in response to an Atypical Squamous Cell of Undetermined Significance (ASC-US) result of the cytological screening.

6. The method of claim 1 , wherein the vial has a vial container carrying the collection chamber and a vial cap mated with the vial container, the method further comprising unmating the vial cap from the vial container to expose the remaining sample portion within the collection chamber.

7. The method of claim 6 , wherein the aliquot chamber is carried by the vial cap.

8. A method of processing a vial having a collection chamber containing a fluid-based sample, a valve mechanism, and an aliquot chamber, wherein the valve mechanism comprises or is coupled to the wall of the aliquot chamber, and wherein the valve mechanism is biased to seal the aliquot chamber from the collection chamber unless actively actuated, the method comprising:

actuating the valve mechanism to unseal the aliquot chamber from the collection chamber;

flowing an aliquot of the sample from the collection chamber into the aliquot chamber while the collection chamber is isolated from an environment exterior to the vial;

terminating actuation of the valve mechanism, wherein the biased valve mechanism automatically seals the aliquot chamber from the collection chamber to isolate the aliquot sample from a remaining portion of the sample in the collection chamber;

removing at least some of the remaining sample portion from the collection chamber while the aliquot chamber is sealed from the collection chamber;

wherein the fluid-based sample is a cervical-vaginal sample; and

performing a cytological examination on the removed remaining sample portion.

9. The method of claim 8 , wherein the at least some of the remaining sample portion is transferred to a microscope slide.

10. The method of claim 8 , further comprising performing a deoxynucleic acid (DNA) test on the aliquot sample.

11. The method of claim 10 , wherein the DNA test is performed in response to an abnormal result of the cytological examination.

12. The method of claim 8 , wherein the vial has a vial container carrying the collection chamber and a vial cap mated with the vial container, the method farther comprising unmating the vial cap from the vial container to expose the remaining sample portion within the collection chamber.

13. The method of claim 12 , wherein aliquot chamber is carried by the vial cap.

14. The method of claim 8 , wherein the vial has an access port, wherein the access port provides access between the aliquot chamber and the exterior of the vial, the method further comprising removing at least some of the aliquot portion from the aliquot chamber via the access port.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →